Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitr Phol Group is a Thailand-based multinational conglomerate and the world's third-largest sugar producer, with a significant and growing presence in the biotechnology and life sciences sectors. The company leverages its agricultural feedstock to produce high-value bio-based products, including pharmaceutical-grade sucrose used as an excipient in drug formulation and functional food ingredients such as xylo-oligosaccharides (XOS) for digestive health. Through its Mitr Phol Innovation & Research Center, the group focuses on Food for the Future, bio-chemicals, and renewable energy solutions. Their operations span the entire value chain from agricultural R&D to the manufacturing of bio-plastics and ethanol. Mitr Phol is a key player in the Southeast Asian bio-economy, transitioning from traditional commodities to advanced bio-based technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitr Phol Group.